Both in Pharmaceuticals
Arcutis Biotherapeutics vs Tango Therapeutics
Over the past year ARQT returned +29.2% and TNGX returned +189.3%; their daily moves had a correlation of 0.28.
ARQT +29.2% TNGX +189.3%Growth of $1, one year, split-adjusted
| Metric | ARQT | TNGX |
|---|---|---|
| Price | $32.00 | $23.17 |
| Market cap | $4.02B | $3.91B |
| Today | +2.37% | +6.48% |
| 1 month | +27.2% | +0.4% |
| 6 months | +36.6% | −4.3% |
| Year to date | +10.2% | +161.5% |
| 1 year | +26.4% | +185.7% |
| Revenue growth (YoY) | +59.3% | −100.0% |
| Gross margin | 91.6% | — |
| Net margin | 11.6% | — |
| P/E (TTM) | 141.0× | — |
| Price / sales | 8.7× | 72.6× |
| Net cash | $129.7M | $1.01B |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 73.2% |
| Short % of float | 18.0% | 31.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).